✦ LIBER ✦

mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation

✍ Scribed by Oliver Waidmann; Wolf-Peter Hofmann; Stefan Zeuzem; Joerg Trojan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib Treatment for Recurrent Hepato

✍ Sotiropoulos, G.C.; Nowak, K.W.; Fouzas, I.; Vernadakis, S.; Kykalos, S.; Klein, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Sorafenib for recurrence of hepatocellul

✍ Arndt Weinmann; Ina Maria Niederle; Sandra Koch; Maria Hoppe-Lotichius; Michael 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 237 KB

High toxicity of sorafenib for recurrent

✍ Katharina Staufer; Lutz Fischer; Barbara Seegers; Eik Vettorazzi; Bjoern Nashan; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 99 KB

Sorafenib for the Treatment of Recurrent

✍ Vitale, A.; Boccagni, P.; Kertusha, X.; Zanus, G.; D'Amico, F.; Lodo, E.; Pastor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Fatal gastric bleeding during sorafenib

✍ Andrea Mancuso; Aldo Airoldi; Raffaella Vigano; Giovambattista Pinzello 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 99 KB

477 Sorafenib but Not Locoregional Thera

✍ Kohli, Ruhail; Lopez, Rocio; Romero-Marrero, Carlos; Menon, KV Narayanan; Aucejo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1019 KB